Venn Life Sciences Stock Price, News & Analysis (LON:VENN)

GBX 10.73 -0.77 (-6.70 %)
(As of 01/22/2018 04:08 AM ET)
Previous CloseGBX 11.25
Today's RangeGBX 10.73 - GBX 10.73
52-Week RangeGBX 0.13 - GBX 22.25
Volume10,000 shs
Average Volume19,201 shs
Market Capitalization£6.48 million
P/E Ratio-536.50
Dividend YieldN/A
BetaN/A

About Venn Life Sciences (LON:VENN)

Venn Life Sciences Holdings plc is a clinical research organization (CRO), which is engaged in providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology and medical device organizations. The Company has the innovation segment, which is focused on developing and commercializing skin technologies. It provides drug development services through its subsidiary, Kinesis Pharma B.V. The Company's drug development services include clinical development, pharmaceutical development, non-clinical/pre-clinical development, drug candidate selection and drug development project management. The Company offers international clinical research services, including protocol development; feasibility and site selection; investigator and site selection; project management; site management and monitoring; vendor management, and quality assurance. The Company has its presence in the United Kingdom, Ireland, France, Netherlands, Germany and Singapore.

Receive VENN News and Ratings via Email

Sign-up to receive the latest news and ratings for VENN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorHealthcare
SymbolLON:VENN
CUSIPN/A
Phone+44-28-90737900

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-536.5
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSGBX (0.02)
Net IncomeN/A
Net Margins-5.30%
Return on Equity-9.35%
Return on Assets-6.62%

Miscellaneous

EmployeesN/A
Outstanding Shares60,280,000

Venn Life Sciences (LON:VENN) Frequently Asked Questions

What is Venn Life Sciences' stock symbol?

Venn Life Sciences trades on the London Stock Exchange (LON) under the ticker symbol "VENN."

Who are some of Venn Life Sciences' key competitors?

Who are Venn Life Sciences' key executives?

Venn Life Sciences' management team includes the folowing people:

  • Allan Leigh Wood, Chairman of the Board (Age 52)
  • Anthony Francis Richardson, Chief Executive Officer, Executive Director (Age 52)
  • Jonathan David Hartshorn, Chief Financial Officer, Director (Age 45)
  • Gracielle Anna Maria Beijerbacht-Schutjens, Executive Director (Age 48)
  • Kees Groen, Executive Director (Age 54)
  • Paul Francis Kennedy, Non-Executive Director (Age 71)
  • Michael Ryan, Non-Executive Director (Age 56)
  • Mary Blake Sheahan, Non-Executive Director (Age 44)

How do I buy Venn Life Sciences stock?

Shares of Venn Life Sciences and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Venn Life Sciences' stock price today?

One share of Venn Life Sciences stock can currently be purchased for approximately GBX 10.73.

How big of a company is Venn Life Sciences?

Venn Life Sciences has a market capitalization of £6.48 million.

How can I contact Venn Life Sciences?

Venn Life Sciences' mailing address is 1 Berkeley Street, LONDON, W1J 8DJ, United Kingdom. The company can be reached via phone at +44-28-90737900.


MarketBeat Community Rating for Venn Life Sciences (VENN)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  32 (Vote Outperform)
Underperform Votes:  53 (Vote Underperform)
Total Votes:  85
MarketBeat's community ratings are surveys of what our community members think about Venn Life Sciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Venn Life Sciences (LON:VENN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AHold
Consensus Rating Score: N/AN/AN/A2.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A

Venn Life Sciences (LON:VENN) Consensus Price Target History

Price Target History for Venn Life Sciences (LON:VENN)

Venn Life Sciences (LON:VENN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
10/5/2016Beaufort SecuritiesReiterated RatingSpeculative BuyView Rating Details
(Data available from 1/22/2016 forward)

Earnings

Earnings History for Venn Life Sciences (LON:VENN)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Venn Life Sciences (LON:VENN) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Venn Life Sciences (LON:VENN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Venn Life Sciences (LON VENN) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Venn Life Sciences (LON:VENN)

Venn Life Sciences (LON VENN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/31/2016Allan WoodInsiderBuy165,000GBX 22£36,300
(Data available from 1/1/2013 forward)

Headlines

Venn Life Sciences (LON VENN) News Headlines

Source:
DateHeadline
What You Must Know About Venn Life Sciences Holdings plc’s (LON:VENN) Major InvestorsWhat You Must Know About Venn Life Sciences Holdings plc’s (LON:VENN) Major Investors
finance.yahoo.com - January 1 at 10:13 AM
What’s Installed For Venn Life Sciences Holdings plc (AIM:VENN)?What’s Installed For Venn Life Sciences Holdings plc (AIM:VENN)?
finance.yahoo.com - December 2 at 4:26 PM
Venn Life Sciences Holdings Plc :VENN-GB: Earnings Analysis: For the six months ended June 30, 2017 : November 9, 2017Venn Life Sciences Holdings Plc :VENN-GB: Earnings Analysis: For the six months ended June 30, 2017 : November 9, 2017
finance.yahoo.com - November 12 at 1:05 PM
Venn Life Sciences Holdings plc (AIM:VENN): Financial Strength AnalysisVenn Life Sciences Holdings plc (AIM:VENN): Financial Strength Analysis
finance.yahoo.com - November 4 at 6:10 AM
Venn Life Sciences Holdings Plc :VENN-GB: Earnings Analysis: For the six months ended December 31, 2016 : June 13, 2017Venn Life Sciences Holdings Plc :VENN-GB: Earnings Analysis: For the six months ended December 31, 2016 : June 13, 2017
finance.yahoo.com - October 6 at 12:24 PM
Venn Life Sciences Focuses On Improving Margins As Interim Loss WidensVenn Life Sciences Focuses On Improving Margins As Interim Loss Widens
www.morningstar.co.uk - September 13 at 10:54 AM
Venn Life Sciences Focuses On Improving Margins As Interim Loss Widens - London South East (registration) (blog)Venn Life Sciences Focuses On Improving Margins As Interim Loss Widens - London South East (registration) (blog)
www.lse.co.uk - September 12 at 11:51 AM
Venn Life Sciences Focuses On Improving Margins As Interim Loss Widens - London South East (registration) (blog)Venn Life Sciences Focuses On Improving Margins As Interim Loss Widens - London South East (registration) (blog)
www.lse.co.uk - September 12 at 11:51 AM
Venn Life Sciences Appoints Christian Milla As Chief Operating Officer - London South East (registration) (blog)Venn Life Sciences Appoints Christian Milla As Chief Operating Officer - London South East (registration) (blog)
www.lse.co.uk - July 26 at 9:44 AM
GUN. Venn Life Scie-GUN. Venn Life Scie-
www.lse.co.uk - April 11 at 9:04 PM
Venn Life Sciences Wins EUR2.5 Million Contract With Sedana MedicalVenn Life Sciences Wins EUR2.5 Million Contract With Sedana Medical
www.morningstar.co.uk - November 11 at 11:24 AM
Venn Life Sciences Sells Innovenn Business For GBP4.7 MillionVenn Life Sciences Sells Innovenn Business For GBP4.7 Million
www.morningstar.co.uk - October 4 at 7:31 AM
Half Year 2016 Venn Life Sciences Holdings PLC Earnings Release - Time Not SuppliedHalf Year 2016 Venn Life Sciences Holdings PLC Earnings Release - Time Not Supplied
biz.yahoo.com - September 28 at 7:46 AM
Venn Life Sciences Loss Narrows As Revenue More Than DoublesVenn Life Sciences Loss Narrows As Revenue More Than Doubles
www.morningstar.co.uk - May 11 at 3:34 PM

SEC Filings

Venn Life Sciences (LON:VENN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Venn Life Sciences (LON VENN) Stock Chart for Monday, January, 22, 2018

Loading chart…

This page was last updated on 1/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.